Dr. Ramon Flick | OMICS International
ISSN: 2157-2526

Journal of Bioterrorism & Biodefense
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 457

Journal of Bioterrorism & Biodefense received 457 citations as per google scholar report

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Dr. Ramon Flick

Different biotech companies, government organizations, universities


Expertise in the field of emerging infectious diseases, 10+ years of hands-on and supervising high-containment work (BSL-3, BSL-4), select agent work, and development of countermeasures against bioterror and agroterror threats

• Field study experience (e.g., SARS outbreak in Hong Kong, Crimean-Congo hemorrhagic fever outbreaks in Iran)

• Design of high-containment facilities

•Vaccine development against High Risk Pathogens

•Translational research Responsible for all antiviral biodefense vaccine development strategies for NewLink Genetics Corporation (BioProtection Systems Corporation is now a wholly owned subsidiary). - One Health concept: focusing mainly on the development of countermeasures for human use, but also on the co-development of livestock vaccines (following the DIVA concept) for certain zoonotic pathogens to address bioterror and agroterror. - Expanding vaccine development program from biothreat pathogens towards emerging infectious diseases.

Research Interest

(1) Vaccine and small molecule inhibitor efficacy testing in collaboration with several academic, industrial and government organizations

(2) Reverse genetics for several emerging infectious diseases (Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, Lassa virus, Junin virus, Nipah virus, Hendra virus, Ebola virus, ...)

(3) Rational vaccine design - Trained 20 scientists in high-containment 'facility', 'suit room' and 'in lab' activities - Generated BSL-4 SOPs and Biosafety Manuals - Select Agent Registration - Mediator between scientists and policy makers

Global Speakers in the subject

Global Experts in the subject